# A Study to Evaluate the Effect of Itraconazole on the Concentration of GSK3923868 in the Blood in Healthy Participants

> **NCT06597500** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 20 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** GSK3923868
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT06597500
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-30
- **Primary completion:** 2024-12-16
- **Final completion:** 2024-12-23
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06597500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06597500, "A Study to Evaluate the Effect of Itraconazole on the Concentration of GSK3923868 in the Blood in Healthy Participants". Retrieved via MORVS 2026-10-15 from https://api.morvs.ai/clinical/NCT06597500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*